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Background: Services for Rheumatoid Arthritis (RA) have evolved with the development of independently led
outreach Rheumatology Practitioner (RP) clinics in Primary Care (PC). Their clinical and cost effectiveness, compared
with Secondary Care (SC) services, has not been assessed. The RECIPROCATE study aims to evaluate their clinical
and cost effectiveness. This part of the study aimed to explore health professionals’ opinions of rheumatology
outreach service.
Methods: Using a qualitative design, semi-structured interviews were conducted with GPs, practice nurses, hospital
doctors and RPs, from one hospital and seven PC practices in Norfolk, to elicit their opinions of the service. The
interviews were analysed using thematic analysis.
Results: All participants agreed the service was supportive and valuable providing high quality personalised
care, disease management, social, and educational support. Advantages identified included convenience,
continuity of care and proximity of services to home. RPs helped bridge the communication gap between PC
and SC. Some participants suggested having a doctor alongside RPs. The service was considered to be cost
effective for patients but there was uncertainty about cost effectiveness for service providers. Few disadvantages
were identified the most recurring being the lack of other onsite services when needed. It was noted that
more services could be provided by RPs such as prescribing and joint injections as well as playing a more
active role in knowledge transfer to PC.
Conclusions: Professionals involved in the care of RA patients recognised the valuable role of the RP outreach
clinics. This service can be further developed in rheumatology and the example can be replicated for other
chronic conditions.Background
Rheumatoid arthritis (RA) is the commonest chronic de-
bilitating, destructive inflammatory arthritis affecting
0.8% of the population [1]. RA is a multisystem disease
that can affect the lungs, skin, heart and eyes and is
associated with an increased risk of cardiovascular dis-
ease equivalent to that seen in type 2 diabetes [2]. The
British Society for Rheumatology (BSR) and European
League Against Rheumatism (EULAR) guidelines for the
management of RA recommend early diagnosis and* Correspondence: Asmaa.abdelhamid@uea.ac.uk
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distribution, and reproduction in any mediumtreatment using disease modifying anti-rheumatic drugs
(DMARDs) or biologic agents [3,4] . Optimal disease
management requires early initiation of DMARDs and
escalation of therapy to reach therapeutic dosages in
order to achieve control of inflammation. Long-term
treatment with immunosuppressive agents is necessary;
hence patients require regular monitoring to assess dis-
ease activity and progression, provide early detection of
drug toxicity, and manage co-morbidities.
The delivery of care for RA patients has changed over
the past two decades. Rheumatology nurses have be-
come an integral part of the multidisciplinary team.
They have expanded their role to include a range of ac-
tivities involved in the assessment and management of
RA such as musculoskeletal examination, medication
monitoring , patient education, joint injections, nursentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Table 1 Interview topics discussed with health professionals
No. Topic
1 Perception of outreach rheumatology service setting in Norfolk
2 The advantages and challenges of the service for patients compared
with hospital service.
3 Services provided currently or should be provided
4 Types of patients, conditions and referral pathways to the service
5 Communication between Primary care outreach and Secondary care
6 Cost effectiveness and quality of care
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follow up clinics [5-8].
Current NHS policy calls for chronic disease assess-
ment and management to be delivered by primary care
close to the patient's home in the community [9]. In
1995, rheumatology nurse outreach clinics were estab-
lished in primary care in Norfolk. These services have
evolved uniquely to provide traditional hospital based
services into seven General Practitioner (GP) practices,
which are independent of consultant care [10-12].
RA patients require regular monitoring to assess dis-
ease progression and early detection of drug toxicity.
Outreach clinics are one means by which specialist ser-
vices can provide care in the community, however, it is
not clear that they are always cost effective. Evidence
from studies of doctors from secondary care in outreach
suggests that the costs are greater, but that patient satis-
faction is high [13,14]. Whether the same is true for
nurse practitioners in the community is not known. Spe-
cialist outreach services are often viewed as dispensable
and easy targets in times of financial stringency. How-
ever these services are valued by patients [15].
There has not been a formal evaluation of the benefits
of this approach to patients with rheumatoid arthritis. In
Norfolk, there is a unique pattern of care with a mixture
of care provided both in hospital and the community by
nurses and doctors independent of SC. What is not
known is whether care provided in the community is as
a good as conventional hospital based care in terms of
clinical benefits, costs, continuity and accessibility for
patients. As part of a detailed appraisal of rheumatology
services provided in primary and secondary care we have
completed a qualitative study exploring the opinions of
doctors and nurses providing rheumatology services in




A qualitative design using semi-structured interviews
was chosen for this study as it allowed the exploration of
health professionals’ views and opinions. It also enabled
health professionals involved in the care of RA patients
to reflect on and assess the service provided.
Setting
The study was set in rural area surrounding a central city
(Norwich). Rheumatology Practitioner clinics are provided
in seven Primary Care practices located in; Holt,
Wymondham, Thorpewood (Norwich), Sheringham,
North Walsham, Fakenham and Attelborough. Secondary
care led services are provided at the main Secondary care
hospital (the Norfolk and Norwich University Hospital) by
a team comprising five consultants, four specialistregistrars and 5 nurse practitioners. Each Primary Care
centre is linked to one RP. Each practitioner is trained in
the assessment of RA, monitoring for drug toxicity and
co-morbidities. Any recommended changes in medication
are made to the local GP. Patients in need of specialist
care, for example assessment for biologic therapies, are re-
ferred back to Secondary care.Participants
We invited all seven participating practices to nominate
one doctor and one practice nurse each. We also invited
all five rheumatology practitioners and five rheumatol-
ogy hospital doctors selected purposively to be represen-
tative of all grades and experience to take part in a semi-
structured interview.Interview
An interview guide was developed by the research team
that included clinicians (see Table 1) based on a framework
of service issues perceived to be relevant to the research
aim. The interview guide was altered to explore emerging
themes after a pilot interview. One interviewer (AA) con-
ducted all interviews at the interviewees’ workplace. The
interviews were audio recorded and later transcribed verba-
tim. Interviews lasted between 20 and 45 minutes.Data analysis
Transcripts were coded and analysed using a Framework
Analysis approach [16]. Different researchers coded
transcripts independently (AA, JM, AW), with good con-
ceptual agreement. This work was used to inform dis-
cussion of the emergent codes and thematic framework.
We grouped codes together under: basic themes, orga-
nising themes and global themes. We actively sought
examples that did not fit with emerging codes and re-
visited transcripts to refine and validate the findings.
The coding frame eventually covered all areas of data,
and corresponded to themes included in the interview
guide plus some emergent issues.
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study, that participation was voluntary and that they
could withdraw from the study without obligation or
giving notice. At the interview, all participants gave their
written consent to participate. All transcripts were de-
identified. The study was approved by Norfolk Research
Ethics Committee08/H0310/127.
Results
Six out of the seven practices with rheumatology out-
reach clinics agreed to take part in the study. All five
RPs and five rheumatology doctors were interviewed. In
total 22 interviews were conducted. Due to a technical
fault, the recordings from two practices were not tran-
scribable. Eighteen interviews (5 RPs, 4PC Drs, 5 SC Drs
(3 consultants and 2 trainees, and 4 practice nurses) in
total were transcribed. Transcripts of 18 interviews plus
written notes from the technically void four interviews
were used in the analysis.
Perception of service
Outreach rheumatology services were perceived, by almost
all interviewees, as supportive and valuable service inde-
pendently led by specialist rheumatology practitioners:
“They are a huge resource for us. . ..taken a big workload
of doctors in hospitals” (Hospital doctor 1)
“We love having the service here. It‘s quick. . .it‘s
marvellous whereas if a patients coming to the Norfolk
and Norwich it is at least a few weeks to be seen
normally”. (GP1)
The service was described as providing high quality per-
sonalised care, providing monitoring of disease for patients
with RA or other inflammatory arthritis requiring disease-
modifying drugs. It also provides a social, educational and
support service for nurses and patients.
“Very useful source of information about what to do
with a patient”. (GP4)
‘The biggest complaint we have from patients here is
that when they go to a secondary care clinic they see
somebody they’ve never seen before, who reads all their
notes, goes right back in their history – so they’ve got
10–20 minutes with that person, 15 minutes is taken
up going back over their history then 5 minutes saying
– well I don’t think you’ve got this actually. And they
come away feeling confused. . . with (RP), she knows
them. It’s a quality appointment” (Practice nurse 4)’
“I see my responsibility out there is to provide support,
monitoring and education to those patients and theirfamilies, and those patients won’t necessarily come
into secondary care” (RP3 )
Current and possible services provided by rheumatology
outreach clinics
Current services identified as being provided by rheu-
matology practitioners included; ordering blood tests
for disease monitoring, assessment of disease activity,
ordering investigations, providing advice and counsel-
ling, and referring to other members of the multidis-
ciplinary team. Although none of the RPs was a qualified
prescriber at the time of conducting the study, they
communicate with PC and SC doctors to request
alteration to dosage of medication based on their assess-
ment of the case. As the RPs work across both PC
and SC this was achievable without patients requiring
extra appointments.
It was also noted that RPs could provide additional
services such as prescribing and joint injections as well
as playing more active role in knowledge transfer to pri-
mary care professionals. However, there was concern
from several GPs working in practices where joint injec-
tions are provided that, although helpful and would ease
their workload; this may deskill GPs currently providing
the service.
“ (RPs) form a management plan and speak to a
doctor if they had any queries” (hospital doctor 2)
“monitoring service . . .link between the community
and the hospital so they’ll highlight, they’ll trouble-
shoot and come to me or one of my colleagues and say
– this is what’s going on, what do you think?”
(Hospital doctor 4)
“I think there might be a role, if there was a protocol
written with pre-agreed parameters to give people a
steroid injection, or to put up a dose of a disease-
modifying drug that had already been started so if
somebody comes to clinic and their rheumatoid isn’t
well-controlled then you can give them a Depo
Medrone injection and put their Methotrexate up from
10 mg to 15 mg a week”. (Hospital doctor 3)
“They can offer advice and support to primary care
professionals in managing patients with
rheumatological diseases” (GP2)
Perceived advantages for patients
All participants identified numerous advantages. The
most commonly recurring were convenience, continuity
of care and providing services closer to home. Specific-
ally, continuity of care was considered important as the
continuity of RP allowed for the development of
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the participants’ medical and social circumstances and
an increased ability to identify changes from the normal
behaviour and functioning of the patient.
“More empathy than doctors and they’ll listen to
patients” (Hospital doctor1)
“Continuity of care is probably the major one” (GP3)
‘That person knows their carers, knows their family,
will go to a funeral with them. She’s brilliant.’
(Practice nurse 4)
“RPs are around for a lot longer than a junior doctor,
better consistency of care and relationship and that
person can assess more quickly, more easily if there
has been any deviation from what’s normal for you,
and that’s beneficial”.(Hospital doctor3)
The service was perceived as saving patients the
time needed to travel to hospital which is particularly
important for an elderly population with a mobility
limiting illness. Accessibility of RPs and the familiar-
ity of clinical environment and staff were also
appreciated.
“for people with chronic disease it’s beneficial for
them to be seen closer to home because it takes much
of the medicalisation out of it and it’s reassuring for
patients” (Hospital doctor2)
“It’s closer. They don’t have as far to travel. They don’t
have as many issues around parking the car or
arranging transport or having to get two buses or that
kind of thing. In this area we quite lucky because you
can get a bus direct to the hospital but even so it takes
time. I think most patients like being in an
environment they’re more familiar with” (GP 2).
“by having me out there, they have a face – one person
who they know, and it’s not just about the disease. I’m
part of their family a lot of the time really. I lot of my
patients who live alone, who are widowed, if they come
into hospital I’ll visit them. I’m often their only visitor.
It’s the pastoral side of things as well. I’ll take the
nighties home and I’ll wash them and bring them back
to the hospital, and I’ll nip in and feed the cat and do
things like that. So I think from that side of things the
benefit’s there. And also I think the GPs benefit greatly
because there’s not there’s not the drain on their
limited resources because I’m there to deal with the
Rheumatology patients because that can be quite big,
especially if they’re flaring or the disease is
uncontrolled” (RP 3)Perceived disadvantages for patients
Few disadvantages were identified. However, the most
frequently identified disadvantage was lack of other
onsite services (for example X-ray) requiring patients to
travel to hospital for access to those services.
“Lack of facilities. You’ve got everything on tap in a
hospital. They’re a bit isolated so there isn’t a doctor
sitting round the corner to ask. A bit unsupported –
with staff and equipment” (Hospital doctor 4)
“Most of the time I don’t think it is an issue but I
suppose if patients were presenting acutely and needed
investigations - needed a scan, needed an x-ray, they
could get it done on site at the same time rather than
having to revisit” (GP 1)
Some participants indicated the lack of back up med-
ical expertise onsite to be a disadvantage.
“I suppose the disadvantages of a nurse running a
clinic independently is that she hasn’t got Consultants
that she can talk to although I know that the nurse
who works here has a very good relationship with the
GPs and she can always talk to the patient’s own GP
about the patient” (Practice nurse 2)
Types of patients
Most participants agreed that RPs should see stable
patients who have had their initial diagnosis and treat-
ment plan formulated in the hospital. Participants also
agreed that RPs should see not only RA patients but
certain other patients with chronic inflammatory arth-
ritis (such as psoriatic arthritis, ankylosing spondylitis)
as long as they are stable. Another point, which was
raised by some participants, is the possibility of using
the service as a triage service or a first contact assess-
ment for rheumatology patients before hospital referral.
While some RPs, GPs and nurses acknowledged that
this does happen in their practices and that they do
refer or accept referrals within their practice for initial
opinion, others said that they could not refer to RPs dir-
ectly and any RP referral has to come through rheuma-
tology consultants. This part of the service seemed to
vary among practices and there was neither consensus
nor clarity whether RPs should provide this service or
not.
“.. all of the different forms of arthritis. Patients with
other connective tissue diseases – we have a lady with
Wegener’s granulomatosis; we have people with Lupus
who are seen in outreach clinics, so I think really the full
spectrum of people who have a diagnosis and who have
been settled and are reasonably controlled” (GP 2)
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that new patients ought to be seen here but if we were
being pressurised to see new patients in an outreach
clinic setting, I would have thought soft tissue
problems would be the sort of thing that could quite
easily succeed in an outreach clinic” (Hospital
doctor 2)
“there are almost no patients who can’t be seen in
Outreach clinics. The question is whether patients
should be seen only in Outreach clinics or virtually
only in Outreach clinics and very rarely in hospital
clinics or patients that should be combined care. I
can’t think of any patient actually – with co-
morbidities, with complex disease, that can’t be seen
in an Outreach clinic and in hospital. What you do is
reduce the number of hospital clinics. I suppose
patients in whom there is a question mark about the
diagnosis – it’s not appropriate if we’re still doing
diagnostic tests, that’s not appropriate for a patient
but most patients can be seen in Outreach clinics but
some will have to be seen in hospital clinics as well”
(Hospital doctor 1)
Cost effectiveness
The service was viewed as being cost effective for
patients as it saves them the financial cost of travelling
to hospital, parking and waiting times. However, partici-
pants were not sure as to its cost effectiveness for staff
and service providers. Some suggested that it may be
cost-effective for service provider as most of the patients
are old and their transport to hospitals is provided by
the NHS. It was recognised that cost effectiveness
requires considered analysis due to its complexity which
needs to take into consideration patient satisfaction and
quality of service provided.
“if you address someone’s concerns early on in the
illness and educate them appropriately that’s bound to
have an effect later on. If you teach them about the
chronic illness they have and encourage them to
manage their disease themselves and again that will
have benefits” (Hospital doctor 3)
“you’d need a health economist to work out the cost-
effectiveness properly. I mean, certainly for patients it’s
better – it’s a lot cheaper – no parking, less travelling.
If you look at it from an environmental point of view,
you would have thought it would be a winner” (GP4)
“For patients they would love it but obviously if you
are looking at the other costs, is it cost-effective? You
would think it would be cost-effective but I suppose
you can always cut costs in places” (Practice nurse 1)Primary/ secondary care communication (and benefits)
Most participants agreed that the service helped to
bridge the communication gap between Primary and
Secondary Care. GPs and nurses felt comfortable com-
municating with RPs if they have a query about a
rheumatology patient. There were some variations, how-
ever, regarding knowledge transfer to Primary Care pro-
fessionals. While some GPs and nurses praised the
rheumatology knowledge and updates they received
from their RPs, some seemed to think more could be
done in this regard with more organised educational ses-
sions conducted by the RPs in their practices.
“easier to ask the outreach practitioner a question
than to try to speak to one of the Consultants or one of
the registrars”. (GP3)
“Things happen quicker”. (RP 2)
“Outreach clinics improve communication between
primary and secondary care rheumatology services”
(Practice nurse 3)
“Communication between GP and practitioner better
therefore communication between GP ad secondary
care improved as RP an intermediary – this helps
patients if there are complications” (GP 1)Training for health professionals
A perceived benefit for Primary Care was that, expertise
normally confined to Secondary Care, was brought dir-
ectly in to the community. Concerns were however
raised by trainees in Secondary care about lack of train-
ing in routine care if these patients were all cared for in
the community.
“Perhaps you might say that there’s a training effect:
the junior doctors in clinics are missing out on that
part of clinical practice so don’t get the same practice
in monitoring disease-modifying drugs as they would if
the patients were coming in but I think that’s a minor
issue” (Hospital doctor 1)Discussion
This is the first study to explore the views of health
professionals from different disciplines on the advan-
tages and disadvantages of Primary Care based clinics
for chronic disease. We studied Primary Care based
rheumatology clinics in Norfolk because of the unique
model of specialist nurse practitioners working in Sec-
ondary Care and general practice. The opinions of parti-
cipants have suggested that this unique service model is
valued by health professionals in both Primary
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ment across both sectors.
The development of care close to home is a key gov-
ernment policy. The policy is, however, controversial be-
cause of fears about fragmentation, loss of continuity of
care and increased costs. The present study suggests that
given an appropriate structure, a community based
rheumatology service can be established which is satis-
factory to both Primary and Secondary Care health pro-
fessionals. Nevertheless, the study did highlight some
areas of concern, particularly a lack of many investiga-
tive facilities in the community. However, routine phle-
botomy is available in community practices, and the
follow up of stable patients in the community rarely
requires diagnostic radiological investigation. In addition
most radiological investigations other than plain radiog-
raphy require a specific visit to hospital. Thus for most
patients there is a trade off between the convenience of
community clinics for the occasional inconvenience of a
trip to hospital which might have been avoided had they
been seen initially on the hospital site.
Chronic diseases such as rheumatoid arthritis require
long-term follow up to monitor the condition, co-mor-
bidities and also response to therapies including toxici-
ties. Much routine follow up can be performed by well
trained nurse practitioners rather than physicians and
many studies have shown equal outcomes [5,17,18].
The hub and spoke model described in this study is,
we believe, is unique. Could our findings be applied in
other geographical areas or specialities? We believe they
could: many of the findings are not specific to our
model, geographical area or RA. In particular there is a
need for close integration.Limitations of the study
The qualitative design enabled us to explore in depth
the opinions of staff across both Primary and Secondary
care.
We only interviewed staff working in practices with an
established rheumatology clinic. It is likely that as the
clinic was well established, they would be more likely to
view it in a favourable light. Practices without outreach
clinics might view their development differently and we
hope to explore this subsequently.
Due to technical reasons we did not have a complete
set of transcripts from each outreach centre. However,
researcher’s written notes from those interviews were
used to complement the analysis. We do not have any
reason to suppose that the centres used differ in any way
from the others.
The sample size was small because we only inter-
viewed staff at one secondary care hospital and seven
general practices. This may limit the generalizability ofour findings. However, many of the key aspects such as
the importance of integration are generally applicable.
There have been several previous studies looking at
the effectiveness of outreach clinics [15,19]. Patient satis-
faction with physician outreach clinics is high [19]. The
key reasons for this are: being seen closer to home, park-
ing facilities and continuity of care. Interestingly in a pa-
tient survey study based in a suburban, industrialised
area of Birmingham UK there was overwhelming desire
from the patients to be seen in the hospital clinic and
not in a Primary care setting with 99.3% of patients pre-
ferring the hospital site [20]. This was attributed to
ready access to all facilities in the hospital and the short
travelling distances. This study was based in an urban/
rural environment only one practice was based within
Norwich City (the others were based up to 45 kilometres
from the hospital). Thus, travelling time is likely to be a
major reason why patients preferred the community
setting.
Gruen, in a review of outreach clinics conducted by
physicians, concluded that whilst the patients benefitted
from outreach clinics they were felt to be inefficient and
inconvenient by physicians because fewer patients were
seen per hour in outreach having allowed for travel time.
[19]. However, in this study the outreach clinics are con-
ducted by nurse practitioners not by doctors and are set
up with a time template identical to that in Secondary
care.
Conclusions
Care closer to home is generally perceived as bringing
significant benefits to the patient with improved out-
comes together with cost savings. However, the evidence
base for this assertion has not been rigorously tested.
The present study is the qualitative component of a lar-
ger study designed to answer this question with a
detailed analysis of the costs involved in providing
rheumatology care in the community. We have analysed
a service, which is closely linked across both Primary
and Secondary care as the practitioners involved work
across both sectors. This integration was highly valued
by those interviewed. Rheumatoid arthritis has a preva-
lence of 0.8%. Therefore, a practice with 10,000 adults
will have 80 patients with RA. Moreover, drug therapies
for RA are becoming increasing complex with the ad-
vent of combination immunosuppressive therapies and
biologic therapies. An individual practice may not, there-
fore, have the expertise to manage this specialist group
of patients. Integration across both sectors enables
skilled personnel to work in the community and achieve
the policy desired care closer to home.
The restructuring of the health service with develop-
ment of GP commissioning consortia is likely to lead to
further development of community based services for
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services can work well but that the key is integration
across Primary and Secondary care. Development of
community services independent of specialist care will
lead to service fragmentation and potentially deterior-
ation in quality of care and increased cost. The costs of
our model to both patient and the health economy are
currently being directly evaluated, with a direct com-
parison of the costs of care in Primary versus Second-
ary care.
We therefore recommend that commissioners estab-
lishing community services consider developing a hub
and spoke model with Secondary care as this will bring
care closer to the community without losing benefits of
access to a specialist centre of expertise. Patients with
stable well controlled disease are most suitable for this
approach, as they are the group of patients least likely to
require Secondary care input. Guidelines and pathways
for management of patients in the community should be
developed to ensure that best practice is shared across
all sites. The expressed opinions and justifications of the
participants with respect to the benefits of RPs becom-
ing qualified and approved prescribers should be
considered.
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